News

Article

Psychedelics Utilization Poll

Author(s):

Psychiatric Times Editors

Answer a quick question about psychedelics!

If approved by the FDA, would you be interested in delivering psychedelics to patients?

Yes, always like to have novel options
Maybe, but first I would like to see it in practical use
I have no interest
Related Videos
Related Content
depression
December 18th 2024

IV Psilocin Benzoate for Major Depressive Disorder: New Phase 2a Results

Leah Kuntz
Here's to a Psychedelic Revolution
April 9th 2022

Here's to a Psychedelic Revolution

Amir Inamdar MBBS, DNB (Psych), MFPM
First Patient Dosed in Phase 3 Study of Psychedelic MM120 in Generalized Anxiety Disorder
December 17th 2024

First Patient Dosed in Phase 3 Study of Psychedelic MM120 in Generalized Anxiety Disorder

Megan McSweeney
David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders
April 6th 2021

David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders

Angela A. Coombs, MD Jennifer Sotsky, MD, MS
patients
November 26th 2024

Moving Along

Dinah Miller, MD
ketamine
October 30th 2024

Psychiatrists Utilizing Ketamine-Assisted Psychotherapy

Miriam Schultz, MD
© 2024 MJH Life Sciences

All rights reserved.